Related Experiment Video
Updated: Sep 20, 2025
Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
LTBP1 Gene Expression in the Cerebral Cortex and its Neuroprotective Mechanism in Mice with Postischemic Stroke
Bo Liu1, Yan Wang1, Dongruo He2
1Department of Neurology, The Second Affiliated Hospital of Qiqihar Medical College, Qiqihar, 161000, China.
Objective:
This study aimed at exploring the expression level of LTBP1 in the mouse model of epilepsy. The mechanism of LTBP1 in epileptic cerebral neural stem cells was deeply investigated to control the occurrence of epilepsy with neuroprotection.
Methods:
qRT-PCR was conducted for the expression levels of LTBP1 in clinical human epileptic tissues and neural stem cells, as well as normal cerebral tissues and neural stem cells. The mouse model of postischemic stroke epilepsy (PSE) was established by the middle cerebral artery occlusion (MCAO). Then, qRT-PCR was conducted again for the expression levels of LTBP1 in mouse epileptic tissues and neural stem cells as well as normal cerebral tissues and neural stem cells. The activation and inhibitory vectors of LTBP1 were constructed to detect the effects of LTBP1 on the proliferation of cerebral neural stem cells in the PSE model combined with CCK-8. Finally, Western blot was conducted for the specific mechanism of LTBP1 affecting the development of epileptic cells.
Results:
Racine score and epilepsy index of 15 mice showed epilepsy symptoms after the determination with MCAO, showing a successful establishment of the PSE model. LTBP1 expression in both diseased epileptic tissues and cells was higher than that in normal clinical epileptic tissues and cells. Meanwhile, qRT-PCR showed higher LTBP1 expression in both mouse epileptic tissues and their neural stem cells compared to that in normal tissues and cells. CCK-8 showed that the activation of LTBP1 stimulated the increased proliferative capacity of epileptic cells, while the inhibition of LTBP1 expression controlled the proliferation of epileptic cells. Western blot showed an elevated expression of TGFβ/SMAD signaling pathway-associated protein SMAD1/5/8 after activating LTBP1. The expression of molecular MMP-13 associated with the occurrence of inflammation was also activated.
Conclusion:
LTBP1 can affect the changes in inflammation-related pathways by activating the TGFβ/SMAD signaling pathway and stimulate the development of epilepsy, and the inhibition of LTBP1 expression can control the occurrence of epilepsy with neuroprotection.
Insights
Latent transforming growth factor beta binding protein 1 (LTBP1) is upregulated in epilepsy. Inhibiting LTBP1 expression offers neuroprotection and controls epilepsy development by modulating inflammation and the TGFβ/SMAD pathway.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Epilepsy is a complex neurological disorder.
- Neural stem cells play a role in epilepsy pathogenesis.
- Understanding molecular mechanisms is crucial for neuroprotection.
Purpose of the Study:
- To investigate the expression of Latent transforming growth factor beta binding protein 1 (LTBP1) in epilepsy.
- To elucidate the role of LTBP1 in epileptic cerebral neural stem cells.
- To explore LTBP1's potential for neuroprotection in epilepsy.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for LTBP1 expression analysis in human and mouse epileptic tissues and neural stem cells.
- Establishment of a postischemic stroke epilepsy (PSE) mouse model using middle cerebral artery occlusion (MCAO).
- Cell proliferation assays (CCK-8) and Western blot analysis to determine LTBP1's mechanism of action and pathway involvement.
Main Results:
- LTBP1 expression was significantly higher in epileptic tissues and neural stem cells compared to normal controls.
- Activation of LTBP1 promoted epileptic cell proliferation, while inhibition reduced it.
- LTBP1 activation upregulated TGFβ/SMAD signaling pathway proteins (SMAD1/5/8) and MMP-13, indicating involvement in inflammation.
Conclusions:
- LTBP1 influences inflammation-related pathways via the TGFβ/SMAD signaling pathway.
- LTBP1 activation contributes to epilepsy development.
- Inhibiting LTBP1 expression demonstrates neuroprotective effects and controls epilepsy.
